One of the consequences of the COVID-19 crisis has been an acceleration toward the digitalisation of doctor’s meetings. In China, Tencent announced last March that the crisis has enabled them to multiply the number of registered patients by 1.6, with a total of 18 million customers in June. At first sight, it looks like a […]
The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of stakeholders from across the life sciences healthcare (LSH) industry. The following is an extract on leadership compiled by project leader Eric Bouteiller of Cornerstone Beijing The first impression listening to CEOs and leaders […]
Despite severe pressure arising from the coronavirus pandemic, global health regulations could be a beneficiary in the new normal.
In the US, a rare disease is defined as affecting 75 in every 100,000 people. In China, there is not yet a specific definition, but it is under study.
To be country manager, it is vital that candidates are the best pharma executives — sharp professionals and masters of commercial excellence.
The Life Sciences and Healthcare practice of Cornerstone International Group is gearing up for increased activity in India. Within only a few months of its formation, the team in India has added three senior level executive search resources effective January 1, 2017. India’s pharmaceutical market is the world’s third largest in volume and the largest […]
China today is gearing up for an explosion in the development of private healthcare that is expected to exceed US $100 billion by 2030.
Taipei, TW, October 28, 2015 — Healthcare CEOs in Taiwan expect to benefit from reforms and growth of healthcare IT in 2016, according to a recent forum organized by Cornerstone International Group here. The meeting of key healthcare leaders launched a new Life Science practice group for Cornerstone International Group in Asia. The organization is […]